0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Natural Killer (NK) Cell Therapeutics - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-5C13853
Home | Market Reports | Health| Health Conditions| Cancer
Global Natural Killer NK Cell Therapeutics Market Research Report 2023
BUY CHAPTERS

Natural Killer (NK) Cell Therapeutics - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-5C13853
Report
December 2023
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Natural Killer (NK) Cell Therapeutics - Market Size

The global Natural Killer (NK) Cell Therapeutics market size is expected to reach US$ 324.8 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029.

Natural Killer (NK) Cell Therapeutics -  Market

Natural Killer (NK) Cell Therapeutics - Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The market is mainly driven by the significant applications of Natural Killer (NK) Cell Therapeutics in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling Natural Killer (NK) Cell Therapeutics market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Natural Killer (NK) Cell Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Natural Killer (NK) Cell Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Natural Killer (NK) Cell Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Natural Killer (NK) Cell Therapeutics covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global Natural Killer (NK) Cell Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services

Scope of Natural Killer (NK) Cell Therapeutics - Market Report

Report Metric Details
Report Name Natural Killer (NK) Cell Therapeutics - Market
Forecasted market size in 2029 US$ 324.8 million
CAGR 3.4%
Forecasted years 2023 - 2029
Global Natural Killer (NK) Cell Therapeutics market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Natural Killer (NK) Cell Therapeutics market, Segment by Type:
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Global Natural Killer (NK) Cell Therapeutics market, by Application
  • Cancer
  • Cardiovascular Diseases
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Natural Killer (NK) Cell Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Natural Killer (NK) Cell Therapeutics - Market size in 2029?

Ans: The Natural Killer (NK) Cell Therapeutics - Market size in 2029 will be US$ 324.8 million.

What is the Natural Killer (NK) Cell Therapeutics - Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the Natural Killer (NK) Cell Therapeutics - Market share by application?

Ans: The cancer segment accounted for a major share in 2019 (66.99%).

What is the market share of major companies in Natural Killer (NK) Cell Therapeutics - Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

What are the Application segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

Ans: The Applications covered in the Natural Killer (NK) Cell Therapeutics - Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Natural Killer (NK) Cell Therapeutics - Market report?

Ans: The Types covered in the Natural Killer (NK) Cell Therapeutics - Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 Market Overview of Natural Killer (NK) Cell Therapeutics
1.1 Natural Killer (NK) Cell Therapeutics Market Overview
1.1.1 Natural Killer (NK) Cell Therapeutics Product Scope
1.1.2 Natural Killer (NK) Cell Therapeutics Market Status and Outlook
1.2 Global Natural Killer (NK) Cell Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2029)
1.4 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.2 Europe Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
2 Natural Killer (NK) Cell Therapeutics Market by Type
2.1 Introduction
2.1.1 Mogamulizumab
2.1.2 Lorvotuzumab Mertansine
2.1.3 Others
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
3 Natural Killer (NK) Cell Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Cardiovascular Diseases
3.1.3 Others
3.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
4 Natural Killer (NK) Cell Therapeutics Competition Analysis by Players
4.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2022)
4.3 Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
4.4 Global Top Players Natural Killer (NK) Cell Therapeutics Headquarters and Area Served
4.5 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Chipscreen Biosciences
5.1.1 Chipscreen Biosciences Profile
5.1.2 Chipscreen Biosciences Main Business
5.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Chipscreen Biosciences Recent Developments
5.2 Affimed NV
5.2.1 Affimed NV Profile
5.2.2 Affimed NV Main Business
5.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Affimed NV Recent Developments
5.3 Altor BioScience
5.3.1 Altor BioScience Profile
5.3.2 Altor BioScience Main Business
5.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Innate Pharma Recent Developments
5.4 Innate Pharma
5.4.1 Innate Pharma Profile
5.4.2 Innate Pharma Main Business
5.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Innate Pharma Recent Developments
5.5 Takeda
5.5.1 Takeda Profile
5.5.2 Takeda Main Business
5.5.3 Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Takeda Recent Developments
5.6 Sorrento Therapeutics
5.6.1 Sorrento Therapeutics Profile
5.6.2 Sorrento Therapeutics Main Business
5.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Sorrento Therapeutics Recent Developments
5.7 NantKwest
5.7.1 NantKwest Profile
5.7.2 NantKwest Main Business
5.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 NantKwest Recent Developments
5.8 Bristol-Myers Squibb
5.8.1 Bristol-Myers Squibb Profile
5.8.2 Bristol-Myers Squibb Main Business
5.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol-Myers Squibb Recent Developments
5.9 NKT
5.9.1 NKT Profile
5.9.2 NKT Main Business
5.9.3 NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 NKT Recent Developments
5.10 Henry Ford Health Services
5.10.1 Henry Ford Health Services Profile
5.10.2 Henry Ford Health Services Main Business
5.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Henry Ford Health Services Recent Developments
6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Natural Killer (NK) Cell Therapeutics Market Dynamics
11.1 Natural Killer (NK) Cell Therapeutics Industry Trends
11.2 Natural Killer (NK) Cell Therapeutics Market Drivers
11.3 Natural Killer (NK) Cell Therapeutics Market Challenges
11.4 Natural Killer (NK) Cell Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Region (2018-2023)
    Table 4. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2023)
    Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2024-2029)
    Table 11. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2023)
    Table 24. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2024-2029)
    Table 26. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2022)
    Table 39. Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
    Table 40. Global Natural Killer (NK) Cell Therapeutics Key Players Headquarters and Area Served
    Table 41. Natural Killer (NK) Cell Therapeutics Product Solution and Service
    Table 42. Global Natural Killer (NK) Cell Therapeutics Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Chipscreen Biosciences Basic Information List
    Table 45. Chipscreen Biosciences Description and Business Overview
    Table 46. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Chipscreen Biosciences (2018-2023)
    Table 48. Chipscreen Biosciences Recent Developments
    Table 49. Affimed NV Basic Information List
    Table 50. Affimed NV Description and Business Overview
    Table 51. Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Affimed NV (2018-2023)
    Table 53. Affimed NV Recent Developments
    Table 54. Altor BioScience Basic Information List
    Table 55. Altor BioScience Description and Business Overview
    Table 56. Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Altor BioScience (2018-2023)
    Table 58. Altor BioScience Recent Developments
    Table 59. Innate Pharma Basic Information List
    Table 60. Innate Pharma Description and Business Overview
    Table 61. Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Innate Pharma (2018-2023)
    Table 63. Innate Pharma Recent Developments
    Table 64. Takeda Basic Information List
    Table 65. Takeda Description and Business Overview
    Table 66. Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Takeda (2018-2023)
    Table 68. Takeda Recent Developments
    Table 69. Sorrento Therapeutics Basic Information List
    Table 70. Sorrento Therapeutics Description and Business Overview
    Table 71. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Sorrento Therapeutics (2018-2023)
    Table 73. Sorrento Therapeutics Recent Developments
    Table 74. NantKwest Basic Information List
    Table 75. NantKwest Description and Business Overview
    Table 76. NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NantKwest (2018-2023)
    Table 78. NantKwest Recent Developments
    Table 79. Bristol-Myers Squibb Basic Information List
    Table 80. Bristol-Myers Squibb Description and Business Overview
    Table 81. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Bristol-Myers Squibb (2018-2023)
    Table 83. Bristol-Myers Squibb Recent Developments
    Table 84. NKT Basic Information List
    Table 85. NKT Description and Business Overview
    Table 86. NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of NKT (2018-2023)
    Table 88. NKT Recent Developments
    Table 89. Henry Ford Health Services Basic Information List
    Table 90. Henry Ford Health Services Description and Business Overview
    Table 91. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Natural Killer (NK) Cell Therapeutics Business of Henry Ford Health Services (2018-2023)
    Table 93. Henry Ford Health Services Recent Developments
    Table 94. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 95. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 96. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 97. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 98. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 99. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 100. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 101. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2018-2023)
    Table 102. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2024-2029)
    Table 103. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 105. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 106. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 107. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 108. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 109. Natural Killer (NK) Cell Therapeutics Market Trends
    Table 110. Natural Killer (NK) Cell Therapeutics Market Drivers
    Table 111. Natural Killer (NK) Cell Therapeutics Market Challenges
    Table 112. Natural Killer (NK) Cell Therapeutics Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Share by Regions: 2022 VS 2029
    Figure 4. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Mogamulizumab
    Figure 11. Global Mogamulizumab Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Lorvotuzumab Mertansine
    Figure 13. Global Lorvotuzumab Mertansine Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Others
    Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Type: 2022 & 2029
    Figure 17. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 22. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Cardiovascular Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Global Natural Killer (NK) Cell Therapeutics Market Size Share by Application: 2022 & 2029
    Figure 26. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 27. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 28. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 29. Latin America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 30. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 31. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 32. Global Top 5 and Top 10 Players Natural Killer (NK) Cell Therapeutics Market Share in 2022
    Figure 33. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
    Figure 34. U.S. Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 35. Canada Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 36. Germany Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 37. France Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 38. U.K. Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 39. Italy Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 40. Russia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 41. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 42. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2018-2029)
    Figure 43. China Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 44. Japan Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 45. South Korea Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 47. India Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 48. Australia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 49. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
    Figure 50. Mexico Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 51. Brazil Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2018-2029)
    Figure 53. Turkey Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 55. UAE Natural Killer (NK) Cell Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 56. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hurthle Cell Carcinoma Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35B1140
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Oncology Based Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6P7589
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Internal Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17G14298
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global External beam Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5C14164
Thu Feb 08 00:00:00 UTC 2024

Add to Cart